C3 and Alzheimer disease: It turned that the expression of Complement component C1Q (C1QA, C1QB and C1QC) and C reactive protein (CRP) was significantly higher in IGF2BP2_high subgroup in AD patients, with no significant difference in C3, suggesting that IGF2BP2 could exacerbate the inflammatory response in the brain tissue of AD patients.